EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.2.1.106 | Respiratory Insufficiency |
33953320 |
Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease. |
causal interaction
therapeutic application
unassigned |
4
3
0 |
| 3.2.1.106 | Sarcoma |
2539799 |
Inhibition of glycosylation processing alters the growth parameters of cells transformed by the oncogene of simian sarcoma virus. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 3.2.1.106 | Speech Disorders |
28039015 |
Longitudinal follow-up to evaluate speech disorders in early-treated patients with infantile-onset Pompe disease. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 3.2.1.106 | Spinocerebellar Ataxias |
22992774 |
Pentanucleotide repeat-primed PCR for genetic diagnosis of spinocerebellar ataxia type 31. |
unassigned |
0 |
| 3.2.1.106 | Spinocerebellar Ataxias |
26663503 |
Voiding Dysfunction in Spinocerebellar Ataxia Type 31. |
diagnostic usage
unassigned |
3
0 |
| 3.2.1.106 | Starvation |
1582534 |
Heterogeneity of glycogen synthesis upon refeeding following starvation. |
unassigned |
0 |
| 3.2.1.106 | Starvation |
8330029 |
Processing and secretion of lysosomal acid alpha-glucosidase in Tetrahymena wild type and secretion-deficient mutant cells. |
ongoing research
unassigned |
4
0 |
| 3.2.1.106 | Vesicular Stomatitis |
6232135 |
Inhibition of N-linked oligosaccharide trimming does not interfere with surface expression of certain integral membrane proteins. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
